L. Stewart
Statistics and Probability · British medical journal · 2002–2021
A researcher in the Science corpus: 17 papers; trusts 5 researchers and is trusted by 14 researchers here, as inferred from the citation graph.
Subfields
- Statistics and Probability — 210 citations into it; #4,018 of 12,932 by trust here, #214 by citations
- General Health Professions — 115 citations into it
Whom L. Stewart trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts L. Stewart overall
- Matthew J. Page
- W. Shadish
- R. Riley
- Joseph E. Gaugler
- J. Yepes‐Nuñez
- D. Rindskopf
- S. Duval
- J. McKenzie
- R. O’Dea
- Evelina Tacconelli
Papers from L. Stewart's perspective
Ordered by how strongly the researchers L. Stewart trusts endorse each paper. Same corpus, a different order for every researcher.
- Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. (International Journal of Surgery)
- PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation (Annals of Internal Medicine)
- PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews (British medical journal)
- The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations (Annals of Internal Medicine)
- Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline (British medical journal)
- PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews (Journal of the Medical Library Association)
- Meta-analysis and the science of research synthesis (Nature)
- Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement. (Journal of Clinical Epidemiology)
- Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a scoping review (Systematic Reviews)
- Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ (BMC Medical Research Methodology)
Their papers
- The nuts and bolts of PROSPERO: an international prospective register of systematic reviews (2012) — 1,395 citations
- Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement. (2015) — 1,945 citations
- Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement (2015) — 18,904 citations
- Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation (2015) — 15,705 citations
- PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews (2020) — 10,812 citations
- PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation (2018) — 31,635 citations
- Practical methods for incorporating summary time-to-event data into meta-analysis (2007) — 5,727 citations
- RoB 2: a revised tool for assessing risk of bias in randomised trials (2019) — 28,662 citations
- To IPD or not to IPD? (2002) — 587 citations
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2020) — 94,440 citations
- The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. (2021) — 3,176 citations
- The PRISMA 2020 statement: An updated guideline for reporting systematic reviews (2021) — 25,061 citations
- Individual Participant Data Meta-Analysis (2020) — 289 citations
- Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. (2010) — 1,743 citations
- Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. (2008) — 890 citations
- Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials. (2008) — 610 citations
- Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. (2007) — 690 citations